Please wait while the formulary information is being retrieved.
ISENTRESS HD (RALTEGRAVIR POTASSIUM)
- HIV infection
600 mg tablet
- 2 tablets (1,200 mg) by oral route once daily
HIV infection
- 2 tablets (1,200 mg) by oral route once daily
- None
Contraindicated
- Acid Controller Complete
- Acid Gone
- Acid Gone Antacid
- Acid Reducer Complete (famot)
- Advanced Antacid-antigas
- Al hyd-Mg tr-alg ac-sod bicarb
- Almacone
- Almacone-2
- alum-mag hydroxide-simeth
- aluminum hydrox-magnesium carb
- aluminum hydroxide gel
- aluminum-magnesium hydroxide
- Antacid
- Antacid Anti-gas
- Antacid Anti-gas Double Str
- Antacid Extra Strength
- Antacid Extra-strength
- Antacid Ii Plus Simethicone
- Antacid Liquid
- Antacid M
- Antacid Maximum Strength
- Antacid Multi-symptom
- Antacid Plus Anti-gas
- Antacid Plus Extra Strength
- Antacid Regular Strength
- Antacid Supreme
- Antacid Tablet
- Antacid With Simethicone
- Antacid-antigas
- Antacid-antigas Ii
- Antacid-simethicone
- Antacid-simethicone Ds
- ASA-acetaminophen-caff-buffers
- aspirin, buffered
- Bayer Plus Extra Strength
- Buffered Aspirin
- Bufferin
- cal phos-mag hydrx-C & D3-phos
- calcium & magnesium carbonates
- calcium carb-mag hydrox-simeth
- calcium carbonate-mag hydroxid
- Comfort Gel
- Comfort Gel Extra Strength
- Complete
- diosmin complex no.1
- Dual Action Complete
- famotidine-Ca carb-mag hydrox
- Flanax
- Foaming Antacid
- Foaming Antacid Extra Strength
- Gaviscon
- Gaviscon Extra Strength
- Gelusil Antacid & Anti-gas
- Geri-lanta
- Geri-mox Antacid-antigas
- Heartburn Antacid
- Liquid Antacid
- Maalox Advanced
- Maalox Maximum Strength
- Mag-al
- Mag-al Plus
- Mag-al Plus Extra Strength
- Maglox
- magnesium hydroxide
- magnesium-aluminum-alginic ac
- Masanti Double Strength
- Mi-acid
- Mintox
- Mintox Maximum Strength
- Mintox Plus
- Pepcid Complete
- Phillips Milk Of Magnesia
- Pro-cal
- Ri-gel
- Ri-gel Ii
- Ri-mox
- Ri-mox Plus
- Riginic
- Rulox
- Supreme Antacid
- Tri-buffered Aspirin
- Tums Dual Action
- Vanquish
- Vasculera
Severe
Moderate
- Acid Control (ranitidine)
- Acid Controller
- Acid Reducer (cimetidine)
- Acid Reducer (famotidine)
- Acid Reducer (ranitidine)
- Acid Relief (cimetidine)
- Aciphex
- Aciphex Sprinkle
- amoxicil-clarithromy-lansopraz
- cimetidine
- Deprizine
- Dexilant
- dexlansoprazole
- Duexis
- esomeprazole magnesium
- esomeprazole sodium
- esomeprazole strontium
- famotidine
- famotidine (PF)
- famotidine (PF)-NaCl (iso-os)
- First-lansoprazole
- First-omeprazole
- Heartburn Prevention
- Heartburn Relief
- Heartburn Relief (famotidine)
- Heartburn Relief (ranitidine)
- Heartburn Relief 24 Hour
- Heartburn Treatment 24 Hour
- ibuprofen-famotidine
- isoniazid-rifamp-pyrazinamide
- lansoprazole
- naproxen-esomeprazole
- Nexium
- Nexium Iv
- Nexium Packet
- nizatidine
- Omeclamox-pak
- omeprazole
- omeprazole magnesium
- Omeprazole+syrspend Sf Alka
- omeprazole-clarith-amoxicillin
- omeprazole-sodium bicarbonate
- pantoprazole
- Pepcid
- Pepcid Ac
- Prevacid
- Prevacid 24Hr
- Prevacid Solutab
- Prevpac
- Prilosec
- Prilosec Otc
- Protonix
- rabeprazole
- ranitidine HCl
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- Rifater
- Tagamet Hb
- Vimovo
- Wal-zan 150
- Zantac
- Zantac Maximum Strength
- Zegerid
- Zegerid Otc
- Lactating mother
Contraindicated
- Rhabdomyolysis
Severe
Moderate
- Myopathy
ISENTRESS HD (RALTEGRAVIR POTASSIUM)
- HIV infection
- None
- Dizziness
- Fatigue
- Headache disorder
- Insomnia
- Nausea
More Frequent
Severe
Less Severe
- Herpes simplex infection
- Herpes zoster
- Acute abdominal pain
- Dyspepsia
- Fever
- General weakness
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Angioedema
- Ataxia
- Eosinophilia
- Gastritis
- Graves' disease
- Guillain-barre syndrome
- Hepatic failure
- Hepatitis
- Hypersensitivity drug reaction
- Kidney stone
- Myopathy
- Polymyositis
- Renal failure
- Rhabdomyolysis
- Skin rash
- Stevens-johnson syndrome
- Suicidal ideation
- Thrombocytopenic disorder
- Toxic epidermal necrolysis
Less Severe
- Conjunctivitis
- Depression
- Diarrhea
- Malaise
- Paranoid disorder
- Symptoms of anxiety
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Raltegravir
Safety and efficacy not established in pre-term infant or weight < 2 kg.
- 1 Day – 27 Days
- Safety and efficacy not established in pre-term infant or weight < 2 kg.
Raltegravir
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects.
Contraindicated
Raltegravir
Cdc does not recommend breastfeeding in hiv-positive women
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Cdc does not recommend breastfeeding in hiv-positive women |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| HIV infection | |
| B20 | Human immunodeficiency virus [HIv] disease |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| O98.7 | Human immunodeficiency virus [HIv] disease complicating pregnancy, childbirth and the puerperium |
| O98.71 | Human immunodeficiency virus [HIv] disease complicating pregnancy |
| O98.711 | Human immunodeficiency virus [HIv] disease complicating pregnancy, first trimester |
| O98.712 | Human immunodeficiency virus [HIv] disease complicating pregnancy, second trimester |
| O98.713 | Human immunodeficiency virus [HIv] disease complicating pregnancy, third trimester |
| O98.719 | Human immunodeficiency virus [HIv] disease complicating pregnancy, unspecified trimester |
| O98.72 | Human immunodeficiency virus [HIv] disease complicating childbirth |
| O98.73 | Human immunodeficiency virus [HIv] disease complicating the puerperium |
| Z21 | Asymptomatic human immunodeficiency virus [HIv] infection status |
| 0-9 | A-Z |
|---|---|
| B20 | Human immunodeficiency virus [HIv] disease |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| O98.7 | Human immunodeficiency virus [HIv] disease complicating pregnancy, childbirth and the puerperium |
| O98.71 | Human immunodeficiency virus [HIv] disease complicating pregnancy |
| O98.711 | Human immunodeficiency virus [HIv] disease complicating pregnancy, first trimester |
| O98.712 | Human immunodeficiency virus [HIv] disease complicating pregnancy, second trimester |
| O98.713 | Human immunodeficiency virus [HIv] disease complicating pregnancy, third trimester |
| O98.719 | Human immunodeficiency virus [HIv] disease complicating pregnancy, unspecified trimester |
| O98.72 | Human immunodeficiency virus [HIv] disease complicating childbirth |
| O98.73 | Human immunodeficiency virus [HIv] disease complicating the puerperium |
| Z21 | Asymptomatic human immunodeficiency virus [HIv] infection status |
Formulary Reference Tool